Haynes BF - Search Results

1

HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities.

Pollara J, Bonsignori M, Moody MA, Liu P, Alam SM, Hwang KK, Gurley TC, Kozink DM, Armand LC, Marshall DJ, Whitesides JF, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Robb ML, O'Connell RJ, Kim JH, Michael NL, Montefiori DC, Tomaras GD, Liao HX, Haynes BF, Ferrari G. Pollara J, et al. Among authors: haynes bf. J Virol. 2014 Jul;88(14):7715-26. doi: 10.1128/JVI.00156-14. Epub 2014 May 7. J Virol. 2014. PMID: 24807721 Free PMC article. Clinical Trial.

2

The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms.

Haynes BF, Liao HX, Patton KL. Haynes BF, et al. Cancer Cells. 1991 Sep;3(9):347-50. Cancer Cells. 1991. PMID: 1721518 Review. No abstract available.

3

Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.

Liao HX, Levesque MC, Patton K, Bergamo B, Jones D, Moody MA, Telen MJ, Haynes BF. Liao HX, et al. Among authors: haynes bf. J Immunol. 1993 Dec 1;151(11):6490-9. J Immunol. 1993. PMID: 7504022

4

NMR-derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus.

de Lorimier R, Moody MA, Haynes BF, Spicer LD. de Lorimier R, et al. Among authors: haynes bf. Biochemistry. 1994 Mar 1;33(8):2055-62. doi: 10.1021/bi00174a011. Biochemistry. 1994. PMID: 7509632

5

Cellular CD44S as a determinant of human immunodeficiency virus type 1 infection and cellular tropism.

Dukes CS, Yu Y, Rivadeneira ED, Sauls DL, Liao HX, Haynes BF, Weinberg JB. Dukes CS, et al. Among authors: haynes bf. J Virol. 1995 Jul;69(7):4000-5. doi: 10.1128/JVI.69.7.4000-4005.1995. J Virol. 1995. PMID: 7539503 Free PMC article.

6

N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.

Liao HX, Lee DM, Levesque MC, Haynes BF. Liao HX, et al. Among authors: haynes bf. J Immunol. 1995 Oct 15;155(8):3938-45. J Immunol. 1995. PMID: 7561101

7

HIV type 1 V3 region primer-induced antibody suppression is overcome by administration of C4-V3 peptides as a polyvalent immunogen.

Haynes BF, Moody MA, Heinley CS, Korber B, Millard WA, Scearce RM. Haynes BF, et al. AIDS Res Hum Retroviruses. 1995 Feb;11(2):211-21. doi: 10.1089/aid.1995.11.211. AIDS Res Hum Retroviruses. 1995. PMID: 7742036

8

Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.

Haynes BF, Yasutomi Y, Torres JV, Gardner MB, Langlios AJ, Bolognesi DP, Matthews TJ, Scearce RM, Jones DM, Moody MA, et al. Haynes BF, et al. Trans Assoc Am Physicians. 1993;106:33-41. Trans Assoc Am Physicians. 1993. PMID: 8036743 No abstract available.

9

Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.

Haynes BF, Torres JV, Langlois AJ, Bolognesi DP, Gardner MB, Palker TJ, Scearce RM, Jones DM, Moody MA, McDanal C, et al. Haynes BF, et al. J Immunol. 1993 Aug 1;151(3):1646-53. J Immunol. 1993. PMID: 8335949

10

Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.

Vu HM, de Lorimier R, Moody MA, Haynes BF, Spicer LD. Vu HM, et al. Among authors: haynes bf. Biochemistry. 1996 Apr 23;35(16):5158-65. doi: 10.1021/bi952665x. Biochemistry. 1996. PMID: 8611499

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

771 results

Search Page